INSR and polycystic ovary syndrome: Collectively, in patients with PCOS, GM dysbiosis leads to elevated LPS levels, which increase intestinal permeability, impair insulin receptor function, and trigger a persistent inflammatory response, driving the progression of the PCOS-IR phenotype.